Clinical Trial Update: Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2 [Phase 3]

View source ↗

Summary

Phase 3 trial update for neoadjuvant chemotherapy in HER2-positive breast cancer (TRAIN-2) is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Breast Cancer, HER2 Positive | Phase 3 | Status: ACTIVE_NOT_RECRUITING